Accelerating the discovery of a cure for ALS.

Scientific Advisors
Board of Directors
< Home


Mr. Nate Boaz is an Associate Principal for McKinsey & Company, and a former Captain in the United States Marine Corps. He holds an MBA with distinction from the Harvard Business School and a B.S. in Political Science from the United States Naval Academy. He co-founded Prize4Life, Inc. in June 2006 and served as the CEO until January 2007. He, with the help of many others, has raised over $4 million for ALS research and ALS research incentives.


Dr. Jan Hammond is the Senior Associate Dean, Director of Faculty Planning and Jesse Philips Professor of Manufacturing at the Harvard Business School. She has previously taught courses in Supply Chain Management, Technology and Operations Management, Business Logistics and After-Sales Service, Decision Support Systems, Quantitative Methods, and Managerial Economics in the MBA program, and has served as the Unit Head for the Technology and Operations Management Unit and as Faculty Chair of the January Cohort of the Harvard MBA Program. She has also taught in several of the HBS Executive Education courses for general managers, including Managing the Supply Chain; Manufacturing in Corporate Strategy; Retailing; and Managing Orders, Vendors, & Customers.

Professor Hammond holds an Sc.B. degree in Applied Mathematics from Brown University and a Ph.D. in Operations Research from the Massachusetts Institute of Technology. Professor Hammond has published widely on the topics of logistics and channel coordination. She consults and teaches at several major U.S. corporations.


Mr. Harvey M. Krueger is a Vice Chairman at Barclays Capital.  He was Vice Chairman Emeritus of Lehman Brothers, and  was involved with that firm and Kuhn Loeb & Co., one of its constituent firms, since 1959. Mr. Krueger served on the Board of Directors of a number of United States and Israeli companies, including, among others, Automatic Data Processing, Inc., Duff & Phelps, Bernard Chaus, Inc., Hansard Global plc, Delta Galil Industries Ltd. and has represented many other entities including the Rockefeller Family and Rockefeller Center, Teva Pharmaceutical Industries Ltd., the Government of Israel, Bank Leumi, Bank Hapoalim and Israel Discount Bank. His non-business activities include serving as Director at Beth Hatefutsoth Museum in Israel; Beth Israel Medical Center in New York, and its parent, Continuum Health Partners. He is former Chairman of the Board of the Cooper-Hewitt-National Design Museum of the Smithsonian Institute.  He was Chairman of the Board of Governors of The Hebrew University of Jerusalem for nine years, President and Chairman of the American Friends of the Hebrew University, and Chairman of the Peres Center for Peace.


Ms. Cynthia T. Mazareas is a Special Counsel at WilmerHale, where she practices law in the firm's Corporate Department and serves as a member of its Life Sciences Group and Technology Transactions and Licensing Group. Ms. Mazareas concentrates her practice in corporate and securities law, including venture capital and public securities offerings, mergers and acquisitions, strategic alliances and licensing arrangements, corporate governance, SEC and Sarbanes-Oxley compliance and counseling emerging businesses. She represents a number of companies in the life sciences, medical device and biopharmaceutical industries. Ms. Mazareas is a member of the Massachusetts Biotechnology Council, the Massachusetts Bar Association and the Boston Bar Association. She received her J.D. from Georgetown University Law Center in 1993 and her B.S. from Boston University in 1985. Ms. Mazareas resides in Nahant, Massachusetts with her husband George and daughter Eleni.


Mr. George K. Mazareas is a native of Lynn, Massachusetts and a graduate of Milton Academy and Tufts University. From 1991 until 2005, Mr. Mazareas served the Commonwealth of Massachusetts in various capacities, including as the Director of Economic Assistance and Co-Chairman of the Massachusetts Family Literacy Consortium. In 2005, Mr. Mazareas was awarded the Commonwealth's Performance Recognition Award for his dedicated years of service to the State's Economic and Business Development efforts. Mr. Mazareas has also served on numerous boards and committees, and in 2005, he was inducted into the Lynn Area Chamber of Commerce Hall of Fame in recognition of his life long achievements in serving the business and community interests of the City of Lynn. After his diagnosis of ALS in the Spring of 2003, Mr. Mazareas turned his attention to raising awareness of the disease and money for the Angel Fund, a non-profit organization that benefits the groundbreaking ALS research being performed at the Cecil B. Day Neuromuscular Laboratory at MGH. Through the efforts of Mr. Mazareas, his family and friends, over $1 million has been raised for the Angel Fund to date. In 2005, Mr. Mazareas was honored with the Angel Fund's Courage Award for his efforts in bringing awareness to the disease and raising funds for a cure. Mr. Mazareas is married and lives in Nahant with his wife Cynthia and their daughter, Eleni.


Dr. David Meeker is Chief Executive Officer of Genzyme Corporation. Prior to his current position, he has served as both the Chief Operating Officer and Executive Vice President, Therapeutics, Biosurgery & Transplant of the same company. Prior to joining Genzyme, Dr. Meeker was Director of the Pulmonary Critical Care Fellowship at the Cleveland Clinic and Assistant Professor of Medicine at Ohio State University. Dr. Meeker attended Dartmouth College and received his medical doctorate from the University of Vermont Medical School. He completed an Internal Medicine residency at Beth Israel Hospital in Boston and a Pulmonary/Critical Care fellowship at Boston University. Dr. Meeker completed the Advanced Management Program at Harvard Business School in 2000. He has authored more than 40 articles and multiple book chapters. Dr. Meeker also serves on the Board of Penwest Pharmaceuticals, Inc.


Mr. Jamie Niven is the Chairman of Sotheby's North and South America. His father, Oscar-winning actor David Niven, died of ALS in 1983. Mr. Niven is also a Trustee of the New York Museum of Modern Art and a member of the Board of Managers of the Memorial Sloan-Kettering Cancer Center. He was first introduced to Prize4Life when he agreed to work with the organization on its inaugural Art Life Spring (A.L.S.) gala held in May of 2010.  


Dr. Vicki Sato is Professor of Management Practice at Harvard Business School, and also Professor of the Practice in the Department of Molecular and Cell Biology, Harvard University. Additionally, she is a business advisor to Atlas Ventures and other enterprises in the biotechnology and pharmaceutical industries. Dr. Sato retired recently from Vertex Pharmaceuticals, where she had served as President since 2000. Prior to becoming President, she also served as Chief Scientific Officer, Senior Vice President of Research and Development, and Chair of the Scientific Advisory Board. Before joining Vertex, Dr. Sato was Vice President of Research at Biogen, Inc, where she led research programs in the areas of inflammation, thrombosis, and HIV disease, and participated in the executive management of the company.

Dr. Sato received her AB from Radcliffe College, and her AM and PHD degrees from Harvard University. Following postdoctoral work at both the University of California Berkeley and Stanford Medical Center, Dr. Sato was appointed to the faculty of Harvard University, first as Assistant and then as Associate Professor of Biology. Dr. Sato is a member of the Board of Directors of the publicly held Bristol Myers Squibb Company, PerkinElmer Corporation, and Alnylam Pharmaceuticals.


Dr. Nicole Szlezák is a consultant at McKinsey & Company, where she serves clients within the health care and pharmaceuticals practice. Prior to joining McKinsey, Nicole was a research fellow in the Sustainability Science Program at Harvard, where she worked on global health governance and international health and science policy. She joined Prize4Life in 2006 and served as the Chief Scientific Officer until January 2008. Before coming to Harvard, Nicole was a clinical researcher at the Institute of Tropical Medicine at the University of Tuebingen, Germany, where her work focused on malaria and schistosomiasis in sub-Saharan Africa. Nicole holds a medical degree from Humboldt University in Berlin, and an MPA and PhD in Public Policy from Harvard.


Mr. Mark Wetzel has been affiliated with Prize4Life since 2007, first as a Board Fellow and then as head of fundraising efforts at Harvard University. His father-in-law courageously battled ALS for over three years, which inspired Mark to join Prize4Life when he was a graduate student. Mr. Wetzel currently works in the Merchant Banking Division of Goldman, Sachs & Co. He holds a B.S. from Boston College and earned his M.B.A. from the Harvard Business School, where he was a Baker Scholar.


Mr. Guy Yamen is a Managing Partner at TPY Capital. He is a former business analyst/engagement manager for McKinsey & Company, as well as a summer associate with Lehman Brothers and a summer analyst with Goldman Sachs. He is also a former financial reporter for the Marker Media. Guy holds an MBA with distinction from the Harvard Business School and an LL.B. (Law degree) and a B.A. in Economics from Tel Aviv University in Israel.


Ms. Amy Yamner Jenkins, Chair of the Board, completed her MBA at Harvard Business School where she was awarded the Horace W. Goldsmith Award for outstanding commitment to the non-profit sector. After business school, Amy spent one year at NewSchools Venture Fund, a venture philanthropy firm working to transform public education through powerful ideas and passionate entrepreneurs, where she was awarded a fellowship from Harvard. In 2007, Amy joined The Monitor Group as a consultant in San Francisco. At Monitor she focuses on strategy and growth, in both the non-profit and commercial sector. Prior to HBS, she co-founded the local affiliate site of a national non-profit organization, where she was in charge of program development as well as fund-raising. She served as a teacher through Teach for America in Oakland, California and has been active on the boards of several non-profit organizations. Amy has a Bachelor of Arts degree from Dartmouth College.